A novel recombinant tumor necrosis factor‐alpha mutant with increased anti‐tumor activity and lower toxicity

International Journal of Cancer

Volumn 48, Issue 5, 1991, Pages 744-748

  Nakamura, Satoshi ^a   Kato, Arata ^a   Masegi, Tsukio ^a   Fukuoka, Masami ^a   Kitai, Kazuo ^a   Ogawa, Hiroko ^a   Ichikawa, Yataro ^a   Maeda, Masahiro ^b   Watanabe, Naoki ^b   Kohgo, Yutaka ^b   Niitsu, Yoshiro ^b  

^a TEIJIN LTD   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; GENE TECHNOLOGY; MOUSE; PRIORITY JOURNAL; TOXICITY;

AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CELL SURVIVAL; FEMALE; FIBROSARCOMA; L CELLS (CELL LINE); LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SARCOMA, EXPERIMENTAL; TUMOR NECROSIS FACTOR;

EID: 0025880621     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910480519     Document Type: Article

References (32)

1. Cachectin and tumor necrosis factor as two sides of the same biological coin
2. Identity of tumor necrosis factor and the macrophage‐secreted factor cachectin
3. Phase I study of recombinant tumor necrosis factor in cancer patients
4. An endotoxin‐induced serum factor that causes necrosis of tumors
5. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines
6. Phase I clinical trial of recombinant human tumor necrosis factor
7. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6‐tetrachloro‐3a,6a‐di‐phenylglycoluril
8. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF‐S) with less toxicity than conventional rTNF‐α in vivo
9. The antitumor function of tumor necrosis factor (TNF). I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity
10. Induction of differentiation of human mono‐blastic and myeloblastic leukemia cell lines by TNF muteins
11. Human recombinant TNF suppresses li‐poprotein lipase activity and stimulates lipolysis in 3T3‐L1 cells
12. Lipoprotein lipase suppression in 3T3‐L1 cells by an endotoxin‐induced mediator from exudate cells
13. Phase‐I study of recombinant human tumor necrosis factor
14. Cleavage of structural proteins during the assembly of the head Of bacteriophage T4
15. Interactions between novel tumor necrosis factor‐α mutants and receptors on tumor and normal cells
16. Extracellular production of human tumor necrosis factor‐α by Escherichia coli using a chemically‐synthesized gene
17. 1 chain constant region polypeptides in Escherichia coli
18. Synergistic effects of recombinant tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis
19. The anti‐metastatic effect of tumor necrosis factor on the artificial metastasis of highly and low‐metastatic clones derived from methylcholanthrene induced‐A fibrosar‐coma cells
20. The antitumor function of tumor necrosis factor (TNF). II. Analysis of the role of endogenous TNF in endotoxin‐induced hemorrhagic necrosis and regression of an established sarcoma
21. Tumor necrosis factor (TNF)
22. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin
23. Antitumor effects of tumor necrosis factor in combination with chemothera‐peutic agents
24. Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor
25. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N‐terminal region
26. Immunomodulatory and immunotherapeutic properties of recombinant γ‐interferon and recombinant tumor necrosis factor in mice
27. Toxic effect of tumor necrosis factor on tumor vasculature in mice
28. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia
29. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon‐γ
30. Intracellular hydroxyl radical production induced by recombinant tumor necrosis factor and its implication in the killing of tumor cells in vitro
31. Suppressive effects of intracellular glutathione on hydroxyl radical production induced by tumor necrosis factor
32. Detection of TNF in blood from patients with Kawasaki syndrome